The purpose of Project Baseline is to map human health so we can convert from a reactive healthcare system to a proactive healthcare system, explained Adrian F. Hernandez, MD, MHS, vice dean, clinical research, Duke University School of Medicine
This page contains sponsored advertising.
In some ways, the United States is progressive in its use of real-world evidence, but there are still areas where other countries do a better job of incorporating such evidence into the health system, explained Adrian F. Hernandez, MD, MHS, vice dean, clinical research, Duke University School of Medicine.
Transcript
What is Project Baseline? What is the purpose and how along into the study are you?
Project Baseline is a study that’s partnered between Duke, Stanford, and Verily, which is a subsidiary of Alphabet, and the main goal is to map human health. Just like the roads have been mapped in the past in terms of understanding how to get from point a from point b, to the same thing in terms of what do we understand about health today and understand transitions from other health states tomorrow or a year from now and then incorporating a variety of signals that would help us map out what someone’s health trajectory is.
An example is having a foundation of genomics or a foundation of what’s in their environment or a foundation of what their microbiome is, and then over time seeing how that changes, and picking up new signals from their daily activity to how they’re feeling to how they’re sleeping, and then incorporating all of that to see if we can have better signals and converting from a reactive healthcare system to a proactive system so that we can actually do something to so-called prevent the car crash in health like for how we do with Google Maps.
Using AI for the Medical Note: Game Changer or a Bridge Too Far?
July 9th 2025During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial intelligence (AI) tools like DeepScribe to enhance documentation efficiency, reduce burnout, and improve patient engagement in clinical settings.
Read More
Managed Care Reflections: A Q&A With David J. Shulkin, MD
July 7th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The July issue features a conversation with David J. Shulkin, MD, a physician and former secretary of the US Department of Veterans Affairs.
Read More
Alexander I. Spira, MD, PhD, of The US Oncology Network, discusses findings from the COCOON trial that show prophylactic treatment reduces dermatological adverse events in patients with non–small cell lung cancer (NSCLC), enhancing their quality of life during amivantamab therapy.
Read More